- Poster presentation
- Open Access
Effect of uphill running on myocardium T2 in mdx mice
© Forbes et al; licensee BioMed Central Ltd. 2012
- Published: 1 February 2012
- Muscular Dystrophy
- Muscle Damage
- Duchenne Muscular Dystrophy
- Short Axis Slice
- Transverse Relaxation Time
Cardiac dysfunction is a major cause of death in Duchenne muscular dystrophy. In mdx mice, the lack of functional dystrophin localized to the cell membrane leads to increased susceptibility to muscle damage and enhanced muscle degeneration. In this study we examined the effect of an uphill running protocol (Michele et al. Circ Res. 105(10):984-93, 2009) on myocardium transverse relaxation time (T2) in young adult mdx mice (16 weeks).
A 4.7T Oxford Magnet with an Agilent/Varian operating system was used to acquire gated T2-weighted single spin-echo images of the left ventricle in the short axis view (TR 750 ms; TE 14-16 ms and TE 30-32 ms; field of view, 25X25 mm2; slice thickness, 1.0 mm; acquisition matrix size, 256 X 128; averages, 8). Images were acquired in C57Bl10 (n=5, male) and mdx (n=5, male) mice using a custom built quadrature volume coil (3.3 cm inner diameter). Mice performed uphill treadmill running at a speed of 6-13m/min with a 10 degree incline for up to one hour. MR data were acquired prior to exercise and after 16-24 hrs of exercise. Short axis slices from the mid-papillary region were selected to calculate mean T2. Mean T2 of the myocardium was calculated using the average signal intensity at each TE by manually tracing the myocardium.
The increase in myocardium T2 following exercise in mdx mice is consistent with dystrophic muscle having an increased susceptibility to muscle damage. Therefore, this in vivo exercise protocol monitored using cardiac MRI may be valuable in future studies to test the efficacy of potential therapeutic treatments in dystrophic murine models. Furthermore, this study supports the notion that T2 may be valuable for evaluating myocardium involvement in muscular dystrophy.
Supported by American Heart Association Post-doctoral Fellowship and Wellstone Muscular Dystrophy Center (1U54RO52646-01A1).
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.